Protocol Summaries: GR184072
| GSK Study ID |
Phase | Title | Status |
|---|---|---|---|
| 113221 | Phase 1 | A Phase 1, Double-Blind, Randomized Clinical Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of SRT501 in Subjects with Colorectal Cancer and Hepatic Metastases | Completed |
| 113222 | Phase 2 | A Phase II, Open-Label, Clinical Study to Assess the Safety and Activity of SRT501 Alone or in Combination with Bortezomib in Patients with Multiple Myeloma | Suspended |